PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
06-May-2025 Electronic Caregiver Launches First-Ever AI-Powered Virtual Care Ecosystem Featuring Interactive Avatar, Now Available via Athenahealth's EHR Network ACCESS Newswire
06-May-2025 CannapharmaRx Continues into New European Market with First Shipment Completed to Germany ACCESS Newswire
06-May-2025 PharmaNest to Present Five Digital Pathology and AI Communications at EASL 2025, Showcasing Advances in Fibrosis and Inflammation Research Newswire
06-May-2025 Biofrontera Inc. to Report First Quarter FY 2025 Financial Results on May 15, 2025 ACCESS Newswire
06-May-2025 Avel eCare Honors Nurses and Reinforces Support Through Telemedicine for Nurse Appreciation Week ACCESS Newswire
06-May-2025 Bulletin from the Annual General Meeting of Vicore Pharma Holding AB (publ) ACCESS Newswire
06-May-2025 aap makes a stable start to financial year 2025 - growth in the region with the highest sales EMEA region aap Implantate AG
06-May-2025 Clarity Clinic Expands PHP/IOP Mental Health Services to Arlington Heights, Bringing Specialized Care to the Northwest Suburbs ACCESS Newswire
06-May-2025 Utah Medical Products, Inc. Announces Quarterly Dividend ACCESS Newswire
06-May-2025 Infinx Acquires i3 Verticals' Healthcare Revenue Cycle Management Business ACCESS Newswire
06-May-2025 Petros Pharmaceuticals Strengthens Partnership with Market Leading Big Data Provider Implementing Key Enhancements to its AI Platform ACCESS Newswire
06-May-2025 Glidewell Launches Fusion With BruxZir(TM) Zirconia ACCESS Newswire
06-May-2025 PharmaNest to Present Five Digital Pathology and AI Communications at EASL 2025, Showcasing Advances in Fibrosis and Inflammation Research ACCESS Newswire
06-May-2025 Nick Health Launches First Global Digital Cancer Care Platform Offering 24/7 Access to World-Class Oncologists ACCESS Newswire
06-May-2025 Clean Biologics appoints Laurent Claisse as CEO to accelerate US and global market expansion  Andrew Lloyd Associates
06-May-2025 Sunshine Biopharma Launches Generic Lurasidone for Schizophrenia in the Canadian Sector of the Global $1.2 Billion Market ACCESS Newswire
06-May-2025 Tharimmune Presents Positive Clinical Data Highlighting TH104 Metabolic Profile and Advances Program for Prophylaxis Against Ultrapotent Opioid Exposure Following FDA Feedback ACCESS Newswire
06-May-2025 Curiteva & Promimic - Bonded by Innovation ACCESS Newswire
06-May-2025 Nerva Completes Mahana Therapeutics Acquisition to Expand Access to Digital Therapies for IBS ACCESS Newswire
06-May-2025 CBD Life Sciences Inc. (CBDL) Announces New Manufacturing Deal With A Southwest-Based Company ACCESS Newswire